Ján Mešter

4.7k total citations
93 papers, 3.8k citations indexed

About

Ján Mešter is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ján Mešter has authored 93 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 40 papers in Genetics and 22 papers in Oncology. Recurrent topics in Ján Mešter's work include Estrogen and related hormone effects (37 papers), Cancer-related Molecular Pathways (14 papers) and Receptor Mechanisms and Signaling (7 papers). Ján Mešter is often cited by papers focused on Estrogen and related hormone effects (37 papers), Cancer-related Molecular Pathways (14 papers) and Receptor Mechanisms and Signaling (7 papers). Ján Mešter collaborates with scholars based in France, United States and United Kingdom. Ján Mešter's co-authors include Etienne‐Emile Baulieu, Gérard Redeuilh, Michèle Sabbah, Thierry Buchou, E.E. Baulieu, Delphine Courilleau, Christine Radanyi, Nadine Binart, Jack‐Michel Renoir and Anne‐Marie Gaben and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ján Mešter

93 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ján Mešter France 32 2.1k 1.5k 585 537 366 93 3.8k
Shutsung Liao United States 30 1.7k 0.8× 951 0.6× 449 0.8× 1.4k 2.7× 212 0.6× 60 3.8k
Ulrich Gehring Germany 32 2.0k 1.0× 1.0k 0.7× 214 0.4× 526 1.0× 412 1.1× 76 2.8k
Gérard Redeuilh France 30 1.7k 0.8× 1.1k 0.7× 810 1.4× 242 0.5× 380 1.0× 48 2.8k
Christine Radanyi France 33 2.1k 1.0× 796 0.5× 256 0.4× 420 0.8× 619 1.7× 48 2.9k
Hannu Rajaniemi Finland 41 2.6k 1.2× 602 0.4× 250 0.4× 485 0.9× 254 0.7× 152 4.6k
Ferdinando Auricchio Italy 38 2.7k 1.3× 2.9k 1.9× 1.2k 2.1× 781 1.5× 384 1.0× 93 5.1k
P. W. Jungblut Germany 23 987 0.5× 1.2k 0.8× 184 0.3× 599 1.1× 198 0.5× 66 2.3k
G. Shyamala United States 34 1.9k 0.9× 2.9k 1.9× 1.3k 2.3× 662 1.2× 1.2k 3.2× 90 5.2k
Steven K. Nordeen United States 40 3.0k 1.4× 2.1k 1.3× 731 1.2× 686 1.3× 756 2.1× 94 5.1k
Thierry Buchou France 21 2.9k 1.4× 725 0.5× 371 0.6× 185 0.3× 183 0.5× 41 3.6k

Countries citing papers authored by Ján Mešter

Since Specialization
Citations

This map shows the geographic impact of Ján Mešter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ján Mešter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ján Mešter more than expected).

Fields of papers citing papers by Ján Mešter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ján Mešter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ján Mešter. The network helps show where Ján Mešter may publish in the future.

Co-authorship network of co-authors of Ján Mešter

This figure shows the co-authorship network connecting the top 25 collaborators of Ján Mešter. A scholar is included among the top collaborators of Ján Mešter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ján Mešter. Ján Mešter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaben, Anne‐Marie, Michèle Sabbah, Gérard Redeuilh, Monique Bedin, & Ján Mešter. (2012). Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells. BMC Cancer. 12(1). 291–291. 19 indexed citations
2.
Bedin, Monique, Maria-Grazia Catelli, Lucien Cabanié, Anne‐Marie Gaben, & Ján Mešter. (2008). Indirect participation of Hsp90 in the regulation of the cyclin E turnover. Biochemical Pharmacology. 77(2). 151–158. 2 indexed citations
3.
Bedin, Monique, Anne‐Marie Gaben, Cécile Saucier, & Ján Mešter. (2004). Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK‐independent cell cycle arrest. International Journal of Cancer. 109(5). 643–652. 42 indexed citations
4.
Redeuilh, Gérard, et al.. (2002). Transcriptional activation by the oestrogen receptor α is modulated through inhibition of cyclin-dependent kinases. Oncogene. 21(37). 5773–5782. 22 indexed citations
5.
Godeau, François, et al.. (2001). Mitogenic activity of high molecular weight forms of insulin-like growth factor-II in amniotic fluid. Journal of Endocrinology. 169(3). 563–572. 7 indexed citations
6.
Buquet-Fagot, Christine, et al.. (1997). Effects of olomoucjne, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines. Anti-Cancer Drugs. 8(6). 623–631. 20 indexed citations
7.
Raymond, Éric, Siham Djelloul, Christine Buquet-Fagot, Ján Mešter, & Christian Gespach. (1996). Synergy between the non-classical thymidylate synthase inhibitor AG337 (ThymitaqR) and cisplatin in human colon and ovarian cancer cells. Anti-Cancer Drugs. 7(7). 752–757. 13 indexed citations
8.
Lallemand, François, Delphine Courilleau, Michèle Sabbah, Gérard Redeuilh, & Ján Mešter. (1996). Direct Inhibition of the Expression of Cyclin D1 Gene by Sodium Butyrate. Biochemical and Biophysical Research Communications. 229(1). 163–169. 95 indexed citations
9.
Buquet-Fagot, Christine, et al.. (1996). Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism. Journal of Cellular Physiology. 166(3). 631–636. 27 indexed citations
10.
Fagot, Dominique, et al.. (1994). Antiproliferative effects of sodium butyrate in adriamycin-sensitive and -resistant human cancer cell lines. Anti-Cancer Drugs. 5(5). 548–556. 11 indexed citations
11.
Fagot, Dominique, Christine Buquet-Fagot, & Ján Mešter. (1993). Mitogenic signaling by prostaglandins in chemically transformed mouse fibroblasts: comparison with phorbol esters and insulin.. Endocrinology. 132(4). 1729–1734. 12 indexed citations
12.
Forgue-Lafitte, M.E., A M Coudray, Dominique Fagot, & Ján Mešter. (1992). Effects of ketoconazole on the proliferation and cell cycle of human cancer cell lines.. PubMed. 52(24). 6827–31. 21 indexed citations
13.
14.
Mešter, Ján, et al.. (1988). Resumption of cell cycle in Balb/c‐3T3 fibroblasts arrested by polyamine depletion: Relation with “Competence” gene expression. Journal of Cellular Physiology. 137(3). 559–564. 14 indexed citations
15.
Seeley, Daniel, Adele J. Wolfson, Ján Mešter, & Etienne‐Emile Baulieu. (1984). The effect of exposure to charcoal and ion-exchange chromatography on the dissociation rate of estrogen from the nuclear estrogen receptor of hen oviduct. Steroids. 44(4). 301–315. 2 indexed citations
16.
Garcı́a, Teresa, Pentti Tuohimaa, Ján Mešter, et al.. (1983). Protein kinase activity of purified components of the chicken oviduct progesterone receptor. Biochemical and Biophysical Research Communications. 113(3). 960–966. 48 indexed citations
17.
Mešter, Ján, et al.. (1982). Activation of the chick oviduct progesterone receptor by heparin in the presence or absence of hormone. Biochemical Journal. 208(2). 399–406. 35 indexed citations
18.
Baulieu, Etienne‐Emile, M. Atger, Martin Best‐Belpomme, et al.. (1976). Steroid Hormone Receptors. Vitamins and hormones. 34. 649–736. 285 indexed citations
19.
Best‐Belpomme, Martin, Ján Mešter, Hadassa Weintraub, & Etienne‐Emile Baulieu. (1975). Oestrogen Receptors in Chick Oviduct. European Journal of Biochemistry. 57(2). 537–547. 56 indexed citations
20.
Mešter, Ján, et al.. (1970). Determination of high-affinity oestrogen-receptor sites in uterine supernatant preparations. Biochemical Journal. 120(4). 831–836. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shutsung Liao Breakdown of academic impact, for papers by Ulrich Gehring Breakdown of academic impact, for papers by Gérard Redeuilh Breakdown of academic impact, for papers by Christine Radanyi Breakdown of academic impact, for papers by Hannu Rajaniemi Breakdown of academic impact, for papers by Ferdinando Auricchio Breakdown of academic impact, for papers by P. W. Jungblut Breakdown of academic impact, for papers by G. Shyamala Breakdown of academic impact, for papers by Steven K. Nordeen Breakdown of academic impact, for papers by Thierry Buchou
Rankless by CCL
2026